These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9251584)

  • 1. Re: Prospective reinfaction outcomes in the Thrombolytic Era Cardizem CD Trial (PROTECT).
    Goodman S; Langer A
    Can J Cardiol; 1997 Jul; 13(7):693, 696. PubMed ID: 9251584
    [No Abstract]   [Full Text] [Related]  

  • 2. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
    Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A
    Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diltiazem comes in from the cold.
    Purcell H; Fox K
    Eur Heart J; 2001 Feb; 22(3):185-7. PubMed ID: 11161925
    [No Abstract]   [Full Text] [Related]  

  • 4. Early stopping of trials.
    Langer A
    Lancet; 1997 Sep; 350(9081):890-1. PubMed ID: 9310634
    [No Abstract]   [Full Text] [Related]  

  • 5. Diltiazem after thrombolysis.
    Drummond GA
    Lancet; 2000 Nov; 356(9241):1604-5. PubMed ID: 11075793
    [No Abstract]   [Full Text] [Related]  

  • 6. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of supraventricular tachyarrhythmias with intravenous calcium channel blockers: are subtle differences worth the cost?
    Cheiman DM; Shea BF; Kelly RA
    Pharmacotherapy; 1996; 16(5):861-8. PubMed ID: 8888080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blockers: an evidence-based review.
    Waters D
    Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing recurrent myocardial infarction. Use of calcium-channel blockers.
    Roberts R
    Postgrad Med; 1988 Jan; 83(1):249-56. PubMed ID: 3275938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ["Magnesium in the cardiology"].
    Smetana R
    Wien Med Wochenschr; 2000; 150(15-16):319-20. PubMed ID: 11105325
    [No Abstract]   [Full Text] [Related]  

  • 12. [Improvement of postinfarct left myocardial contractile function after administration of diltiazem].
    Gambelli G; Donati R; Mezzanotte R; Pozzar F; Cesario AS; Schiavo B; Pau F
    G Ital Cardiol; 1998 Mar; 28(3):249-58. PubMed ID: 9561879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists in the therapy of acute myocardial infarction.
    Stazi F; Verde M; Stazi C; Di Gennaro M
    Minerva Cardioangiol; 2000; 48(1-2):29-38. PubMed ID: 10829585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subgroup analysis of the NORDIL trial.
    Thijs L; Staessen JA; Wang J; Fagard R
    J Hypertens; 2002 Jun; 20(6):1085-7. PubMed ID: 12023676
    [No Abstract]   [Full Text] [Related]  

  • 15. Is diltiazem as effective as diuretics and beta-blockers in preventing complications from hypertension?
    Adelman A
    J Fam Pract; 2000 Nov; 49(11):1049. PubMed ID: 11093573
    [No Abstract]   [Full Text] [Related]  

  • 16. [Stable angina pectoris: what is the role of calcium antagonists?].
    Tiberti G; Bossi M
    G Ital Cardiol; 1997 Oct; 27(10):1062-6. PubMed ID: 9410778
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium antagonists and secondary prevention of myocardial infarction; [comment].
    Rosendorff C
    Lancet; 2000 May; 355(9217):1738-9. PubMed ID: 10832818
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of heart rate-lowering calcium antagonists: lessons from controlled trials.
    Messerli FH; Michalewicz L
    Am Heart J; 1997 Aug; 134(2 Pt 2):S21-4. PubMed ID: 9313620
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium-channel antagonists in cardiovascular disease.
    Holdright DR
    Br J Hosp Med; 1997 Jun 4-17; 57(11):552-6. PubMed ID: 9307671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.
    Domanski M; Antman EM; McKinlay S; Varshavsky S; Platonov P; Assmann SF; Norman J
    Control Clin Trials; 2004 Dec; 25(6):553-62. PubMed ID: 15588742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.